Atazanavir
Across all fields, 2 papers: 1 observational study in people, 1 review
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Humans1
Outcomes
1Senescence-associated secretory phenotype (SASP)
upin human cells1
1 study
Senescence-associated secretory phenotype (SASP)
upin human cells1
Atazanavir induces senescence-associated secretory phenotype (SASP) in human cells.
“In comparison with FB-E, FB-UVB and FB-ATV showed higher levels of senescence and expression of the genes related to the senescence-associated secretory phenotype (SASP)”
Cellscompared to elderly-derived fibroblasts (FB-E)skin
Systemic comparison of molecular characteristics in different skin fibroblast senescent models
Chinese medical journal
Latest
1 paper in 12 monthsClinical Pharmacokinetics
Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005
Systematic reviewMechanisms
The Lancet Digital Health
Deep learning assessment of senescence-associated nuclear morphologies in mammary tissue from healthy female donors to predict future risk of breast cancer: a retrospective cohort study
Cohort study of 4,382 peopleBreast cancer
Chinese Medical Journal
Systemic comparison of molecular characteristics in different skin fibroblast senescent models
Study in peopleCellular senescence
bioRxiv
IGFBP2 protects against pulmonary fibrosis through inhibiting P21-mediated senescence
Preprint: experiments in animalsMechanisms
bioRxiv
A Proteomic Atlas of Senescence-Associated Secretomes for Aging Biomarker Development
Preprint: experiments in cellsAI & data
Antiviral Therapy
Impact of CCR5, integrase and protease inhibitors on human endothelial cell function, stress, inflammation and senescence
Experiments in cellsInterventions